Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Metabolic Syndrome × Testosterone × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Neoplasms 5 Breast Neoplasms 3 Testicular Neoplasms 2 Polycystic Ovary Syndrome 2 Sleep Apnea, Obstructive 1 Sleep Apnea Syndromes 1 Sexuality 1 Sexual Dysfunction, Physiological 1 Obesity 1 Neoplasm Metastasis 1 Muscle Weakness 1 Multiple Endocrine Neoplasia Type 1 1 Motor Activity 1 Metabolic Syndrome 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Infertility 1 Hypogonadism 1 Hot Flashes 1 Fatigue 1 Dyspareunia 1 Arthralgia 1

Interventions

Metformin 2 Ethinyl Estradiol 2 Blood Pressure 2 drospirenone and ethinyl estradiol combination 1 drospirenone 1 Vascular Stiffness 1 Ultrasonography 1 Triptorelin Pamoate 1 Testosterone 1 Sugars 1 Spironolactone 1 Pulse Wave Analysis 1 Preoperative Exercise 1 Phlebotomy 1 Orchiectomy 1 Medical History Taking 1 Magnetic Resonance Spectroscopy 1 Inositol 1 Human Growth Hormone 1 Hematologic Tests 1 Growth Hormone 1 Flutamide 1 Exercise 1 Etanercept 1 Electrocardiography 1 Echocardiography 1 Diet, Reducing 1 Diet, Mediterranean 1 Diet, Fat-Restricted 1 Diet Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02991209 2020-03-06

Einstein

Rigshospitalet, Denmark

Phase 2/3 Completed

Testicular Neoplasms, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡